Safety and Efficacy Study of Bimatoprost, Latanoprost, and Travoprost in Patients With Elevated Intraocular Pressure (IOP) and Open-Angle Glaucoma (OAG).

Trial Profile

Safety and Efficacy Study of Bimatoprost, Latanoprost, and Travoprost in Patients With Elevated Intraocular Pressure (IOP) and Open-Angle Glaucoma (OAG).

Completed
Phase of Trial: Phase IV

Latest Information Update: 05 Jan 2012

At a glance

  • Drugs Bimatoprost; Latanoprost; Travoprost
  • Indications Glaucoma; Ocular hypertension
  • Focus Therapeutic Use
  • Sponsors Allergan
  • Most Recent Events

    • 05 Jan 2012 Actual patient number is 1099 according to ClinicalTrials.gov.
    • 05 Jan 2012 Actual end date (Sep 2009) added as reported by ClinicalTrials.gov.
    • 05 Jan 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top